This summary reports features key points from the contributions at the 26th March 2021 HCV Action webinar looking at hepatitis C service recovery in England. Speakers at the webinar included: Prof Graham Foster, National Clinical Lead for ODNs, NHS England; Mark Gillyon-Powell, Head of Programme – HCV Elimination, NHS England/NHS Improvement; Stacey Smith, Director of Nursing, Humankind; Colin Lawton, Northern Regional Prison Lead, The Hepatitis C Trust; and Julia Sheehan, Women’s Prisons Peer Coordinator, The Hepatitis C Trust.
Cost-effectiveness of opt-out HCV and HBV testing in A&E in the UK
Download
Research published in Value in Health in December 2020 found that testing for hepatitis C and hepatitis B in A&E departments in the UK is highly likely to be cost effective due to high rates of hepatitis among people who attend A&E. Based on a study of two London hospitals, the paper argues that, just as NICE guidelines recommend testing people attending A&E for HIV, hepatitis C and hepatitis B testing should also occur.
